Researcher profile

Guadalupe Gómez Melis

Guadalupe Gómez Melis contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate

Trust snapshot

Quick read

Trust 13 - UnverifiedVerification L1Unclaimed author
2works
0followers
4topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

2 published item(s)

preprint2026arXiv

Semiparametric estimation of GLMs with interval-censored covariates via an augmented Turnbull estimator

Interval-censored covariates are frequently encountered in biomedical studies, particularly in time-to-event data or when measurements are subject to detection or quantification limits. Yet, the estimation of regression models with interval-censored covariates remains methodologically underdeveloped. In this article, we address the estimation of generalized linear models when one covariate is subject to interval censoring. We propose a likelihood-based approach, GELc, that builds upon an augmented version of Turnbull's nonparametric estimator for interval-censored data. We prove that the GELc estimator is consistent and asymptotically normal under mild regularity conditions, with available standard errors. Simulation studies demonstrate favorable finite-sample performance of the estimator and satisfactory coverage of the confidence intervals. Finally, we illustrate the method using two real-world applications: the AIDS Clinical Trials Group Study 359 and an observational nutrition study on circulating carotenoids. The proposed methodology is available as an R package at github.com/atoloba/ICenCov.

preprint2020arXiv

Decision tool and Sample Size Calculator for Composite Endpoints

Summary points: - This article considers the combination of two binary or two time-to-event endpoints to form the primary composite endpoint for leading a trial. - It discusses the relative efficiency of choosing a composite endpoint over one of its components in terms of: the frequencies of observing each component; the relative treatment effect of the tested therapy; and the association between both components. - We highlight the very important role of the association between components in choosing the most efficient endpoint to use as primary. - For better grounded future trials, we recommend trialists to always reporting the association between components of the composite endpoint. - Common fallacies to note when using composite endpoints: i) composite endpoints always imply higher power; ii) treatment effect on the composite endpoint is similar to the average effects of its components; and iii) the probability of observing the primary endpoint increases significantly.